ÂÜÀòÂÒÂ×

H. Lawrence Remmel, Esq. is a Partner at Pryor Cashman LLP, a New York law firm, where he serves as Chair of the Banking and Finance practice group. His practice includes corporate and banking financing issues relating to the Investment Company Act of 1940 and intellectual property and licensing issues, particularly in the biotechnology and bio-cosmeceutical areas. Larry is a board member of Atossa Therapeutics, Inc., a company focused on the development and marketing of pharmaceuticals for the treatment of breast cancer and similar conditions; CytoDel, Inc., an early-stage biopharmaceutical company developing products for biodefense, neuronal drug delivery, and musculoskeletal and aesthetic medicine; and Aufbau Holdings, Ltd., an Irish company developing diagnostics and therapeutics in ophthalmology, oncology and other areas.